Materialise Reports 6.8% Revenue Growth in Q4 2025, Driven by Medical Division
Materialise achieved €70.2 million in revenue for Q4 2025, a 6.8% increase year-on-year. The medical division grew by 16.3%, while overall annual turnover was €267.6 million. The company noted weaker demand in manufacturing and negative currency effects. Adjusted EBIT for Q4 reached €4.0 million, with a gross margin of 58.1%. Despite a lower net profit of €7.7 million for the year, Materialise highlighted its financial strength with €134 million in cash and ongoing investments in R&D.
Theia Market Signal Identification - AI Assisted
Materialise reported €70.2 million in revenue for Q4 2025, up 6.8% from the previous year, with the medical division driving a 16.3% increase. Annual turnover was €267.6 million, nearly unchanged from 2024, attributed to weaker manufacturing demand and currency impacts.
The gross margin improved to 58.1% in Q4, with adjusted EBIT at €4.0 million, contrasting with a loss in the prior year. Net profit for 2025 was €7.7 million, lower than 2024. The company emphasized its solid financial standing with €134 million in cash, continued R&D investments, and a strategic shift in manufacturing aimed at aerospace and defense markets.
Comments